We conducted a retrospective follow-up study to determine 
Introduction
The choice of treatment for oral squamous cell carcinoma (SCC) according to the Danish Head and Neck Cancer Group (DAHANCA) guidelines depends on tumor stage and histopathologic factors. Surgery is the preferred monotherapy for patients with a low risk of recurrent disease (T1/2N0M0), while a combination of surgery and either radiotherapy (RT) or chemoradiotherapy is recommended for high-risk patients.
Successful treatment with radical surgery demands a minimum macroscopic resection margin of 10 mm and a minimum microscopic margin of 5 mm to achieve free margins. 1 The width of the margin cited on the pathology report will often differ from the 10-and 5-mm margins that the surgeon intended. This can be attributable to several factors, such as the anatomy of the involved oral cavity, the shrinking of the tumor and surrounding tissue after removal, fixation of the tissue, and microscopic changes. [2] [3] [4] [5] Involved margins demand additional treatment, but often there is a group of patients at intermediate risk for recurrent disease whose resection margins are 1 to 5 mm.
While there is general agreement on the type of treatment for patients at low and high risk for recurrence, there is controversy regarding the primary treatment for patients with close surgical margins, who are at intermediate risk, as studies have found different locoregional control and long-term survival rates after combined surgery and RT versus surgery alone. [6] [7] [8] In 2012, a review by Brown et al found that both overall survival rates and disease-free survival rates were better in patients who were treated with combined therapy than in those treated only surgically (94 vs. 84%, no p value reported, and 68 vs. 38%, p <0.005, respectively) 8 Conversely, a similar study by Wong et al 6 published that same year found that locoregional control rates were better in the surgery-only group, although not significantly so (15 vs. 8%, p = 0.29). Another study by Brown Welinder, laWaetz, dines, Homøe et al, 9 published in 2007, found that long-term survival rates were significantly better in the surgery-only group (74 vs. 54%, p = 0.002), although locoregional control rates were slightly worse in patients who did not receive postoperative RT (15 vs. 23%, p = 0.19).
When planning treatment, the benefit of combined therapy should be considered along with the potential long-term side effects of RT, such as xerostomia and osteoradionecrosis. 9, 10 Some authors have advocated a watch-and-wait approach after surgery before deciding whether to administer RT. 9, 11 They contend that repeat surgery and subsequent curative RT can be performed in the case of a recurrence. On the other hand, the DAHANCA guidelines recommend immediate additional RT to reduce the risk of a recurrence.
In this article, we describe our study to determine if adjunctive RT had an effect on disease-free survival in patients with oral SCC who were found to have close surgical margins after tumor resection.
Patients and methods
For this retrospective follow-up study, we reviewed the records of 178 consecutively presenting patients with oral SCC who had been treated at Rigshospitalet, University Hospital of Copenhagen, from January 2010 through December 2011 and followed until May 31, 2015 at the latest.
Patients were excluded if they had presented with a recurrence of oral SCC (n = 38), if their tumor had been sufficiently removed during a biopsy procedure (n = 12), if they had been previously treated with RT in the head and neck area (n = 11), if histology revealed only carcinoma in situ (n = 5), or if their tumor was a metastasis (n = 2). After these exclusions, our study population consisted of 110 patients-72 men and 38 women, aged 30 to 94 years (median: 66) at the time of diagnosis.
Data collection. Data were retrieved from our hospital's electronic medical records and pathology reports. In addition to demographic data, we compiled information on each patient's date of diagnosis, date of primary surgery, recurrence at the original tumor site or at a nodal site, any distant metastasis, tobacco history, and the date and cause of death, if applicable. These data were compared with previously collected data on the same cohort described in a study published by two of the present study's authors, Lawaetz and Homøe. 11 Resection margins were recorded in millimeters on all edges (anterior, posterior, lateral, medial, and deep). The smallest margin was then categorized according to the The Royal College of Pathologists as either clear, close, or involved for margins that were located more than 5 mm, 1 to 5 mm, or less than 1 mm from the primary tumor, respectively. 1 The margin closest to the middle of the oral cavity was categorized as the medial margin; the opposite margin, the lateral; the margin closest to the front of the oral cavity, the anterior; and the margin closest to the back, the posterior. The margin closest to the dysplasia or carcinoma in situ did not qualify as a tumor margin and was not used in this study.
The decision as to whether postoperative RT should be administered was discussed at a multidisciplinary team (MDT) conference with an attending head and neck surgeon and an oncologic radiotherapist after the pathology report had been completed. Based on the decision reached at the MDT conference, patients gave their informed consent regarding either postoperative RT or a postoperative watch-and-wait strategy.
Recurrence was evaluated by the head and neck surgeon on the basis of a clinical examination and findings on computed tomography, magnetic resonance imaging, and/or positron-emission tomography; ultrasonography was performed when relevant. Imaging findings were confirmed by fine-needle aspiration cytology or histologic examination.
Overall survival was defined as the time from the initial diagnosis to the date of death from any cause. Disease-free survival was defined as the time from surgery to the initial development of a recurrence or a local, regional, or distant metastasis.
Statistical analysis. Univariate analyses were performed with the Statistical Package for the Social Sciences software (v. 19.0). The chi-square test and Fisher exact test were used to explore relationships between categorical variables. Rates of overall and disease-free survival were estimated with the use of the Kaplan-Meier model. Univariate comparison of survival was performed using the log-rank test.
Ethical considerations. According to the Danish Ethical Committee, ethical approval was not necessary at the time of data collection because the patients were not contacted. The study was therefore granted an exemption.
Results
For this study cohort, data regarding tumor site, tumor size, TNM classification, margin status, tumor thickness, perineural invasion, character of the invasive front, vascular permeation, resection margins on all surfaces, postoperative RT, and re-resection after the primary surgery were described by Lawaetz and Homøe. 11 As they reported then, the 110 patients in the present study were comparable to patient samples in similar retrospective studies with regard to age, sex, and tumor distribution.
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Welinder, laWaetz, dines, Homøe days postoperatively from pneumonia and sepsis; he had not been evaluated at the MDT conference regarding postoperative RT before his death. No patients were lost to follow-up. Tumor site. Tumors were located in the tongue in 52 patients (47.3%), the floor of mouth in 47 (42.7%), the gums in 6 (5.5%), and the retromolar space in 5 (4.5%).
Type of surgical margins. In total, 40 patients (36.4%) had microscopically free resection margins, 55 (50.0%) had close resection margins (including the patient who died 12 days postoperatively, whose data are hereinafter not included in our analysis unless noted), and 15 (13.6%) had involved margins. Postoperative RT had been administered to 2, 17, and 12 patients, respectively (table 1) .
Re-resection. Three patients underwent surgical re-resection. Two of these 3 patients were among the 37 with closed margins who had not received postoperative RT. Of the remaining 35 patients, 16 refused a second operation; the reason for the other 19 patients was not recorded. The other patient who underwent re-resection had involved margins.
Recurrence. In all, 23 of the 109 evaluable patients (21.1%) experienced a recurrence. The duration from treatment to recurrence ranged from 55 days to 3.6 years (median: 234 days).
Margin status. With respect to margin status, recurrence was seen in 4 of the 40 patients with free margins (10.0%), 15 of the 54 evaluable patients with close margins (27.8%), and in 4 of the 15 patients with involved margins (26.7%). The distribution of recurrences between the RT and non-RT subgroups by margin status is shown in table 1.
Tumor site. With respect to the primary tumor site, recurrence was seen in 14 of the 52 patients with a tongue tumor (26.9%), in 8 of 47 with a floor of mouth tumor (17.0%), in 1 of 6 patients with a tumor of the gums (16.7%), and in none of the 5 patients with a retromolar space tumor. We found no significant association between tumor recurrence and specific tumor location (p = 0.34). In all, 12 patients had a local recurrence, 8 had a nodal recurrence, and 3 had a distant metastasis. The distribution of recurrences between the RT and non-RT subgroups by tumor site and by TNM category is shown in table 2.
Risk factors for patients with close margins. Among the patients with close surgical margins, the RT group had significantly more nodal involvement (p = 0.009), more advanced overall cancer stage (p = 0.033), and a greater incidence of perineural invasion (p = 0.028) than the non-RT group. No difference was seen regarding T and M categories, perivascular invasion, bone invasion, and invasive front (table 3) .
Survival. A total of 35 patients (31.8%) died during the study period. The interval between diagnosis and death ranged from 29 days to 5.1 years (median: 2.1 yr).
Disease-free survival. The 3-year disease-free survival rate among the 110 patients was 81.0% ( figure, A) . Among the patients with close margins, we found no statistically significant difference in disease-free survival between those who did and did not receive postoperative RT (p = 0.72). We also found no significant difference between patients with floor of mouth tumors and tongue tumors (p = 0.34).
Overall survival. The overall survival rate at 3 years was 78.2% ( figure, B) .
Smoking. Of the 110 patients, 69 (62.7%) reported active smoking at the time of the diagnosis, 29 (26.4%) had previously smoked, and 12 (10.9%) had never smoked. We were able to obtain information on pack-years from 77 of the 98 current and previous smokers (78.6%); the duration of their consumption ranged from 6 to 180 pack-years (median: 40).
Among the 54 evaluable patients with close margins, 17 of 17 RT patients were active or previous smokers, as were 32 of 37 non-RT patients. We found no statistically significant difference in smoking in the group with close margins between the RT and non-RT patients (p = 0.16). We also found no significant difference in disease-free 
Discussion
In our 3-year follow-up study, we found no significant association between tumor recurrence and specific tumor location in the oral cavity (p = 0.34), although the patients with floor of mouth tumors had a significantly higher incidence of inadequate resection margins, as reported previously by Lawaetz and Homøe. 11 Close or involved margins were significantly more common in the deep edges than in the other four edges.
Floor of mouth anatomy is challenging for surgeons because of natural boundaries, soft-tissue extension, and poor overview. McMahon et al have shown that a reduction in the risk of inadequate surgical margins is possible with the use of improved imaging and by rigorous surgical approaches. 5 In patients with close margins, our finding that there were no significant differences in T and M categories, perivascular invasion, bone invasion, and invasive front between the RT and non-RT patients corresponds with findings reported in other studies. 6, 9, 12, 13 DAHANCA guidelines recommend monotherapy-primarily surgery, but in rare cases RT-for patients with stage I (T1N0), stage II (T2N0), and some stage III (T1N1, T2N1) oral SCCs. Surgical removal of the primary tumor is preferred if radical resection can be achieved with a functionally and aesthetically acceptable result.
If a tumor is not radically removed (i.e., if a micro-or macroscopic tumor is too close to the resection margin), postoperative RT is recommended. All stage III and IV cancers are treated with combination therapy. In our study, we did not adhere entirely to these guidelines because not all patients with close or even involved surgical margins received RT (quite a few because they refused it). Even when frozen sections are obtained regularly during surgery, the exact surgical margin cannot be confirmed until the tissue has been evaluated histopathologically. Our study found that perioperative evaluations of the adequacy of surgical margins were used in the postoperative evaluation to decide whether postoperative RT should be administered. However, any difference between the width of a surgeon's resection margins and a pathologist's resection margins should be viewed in light of the fact that tissue shrinks by 21 Volume 97, Number 9
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NO DIFFERENCE IN DISEASE-FREE SURVIVAL AFTER ORAL CANCER RESECTION WITH CLOSE TUMOR MARGINS IN PATIENTS WITH AND WITHOUT POSTOPERATIVE RADIOTHERAPY
to 59% during the interval between surgery and histopathologic analysis. [2] [3] [4] 13 It is well known that combined therapy with surgery and postoperative RT can increase the incidence of severe and irreversible side effects such as xerostomia and osteoradionecrosis of the mandible, both of which have an influence on quality of life. 9, 10 The trend toward a watch-and-wait approach regarding postoperative RT in patients with close margins makes it possible for patients to receive potentially curative RT later if there is tumor recurrence. 6, 7, 14 In our study, patients with close margins who received postoperative RT had significantly more nodal involvement, significantly more advanced cancer stage, and a significantly greater frequency of perineural invasion than did patients with close surgical margins who did not receive RT. However, this finding might have been the result of a selection bias, since cancer stage and histopathologic characteristics were used at the MDT conference as a basis on which to advise patients as to whether they should undergo postoperative RT. 9 Nevertheless, our results still indicate that a watch-andwait strategy should at least be considered for selected patients with close surgical margins.
We found that smoking had no effect on outcomes. Data on other potential confounding variables, such as alcohol use and immunosuppression therapy, were not available for all patients.
In our study, the 3-year disease-free survival rate was 81.0%. No other studies have reported a 3-year disease-free survival rate or a 3-year recurrence rate. However, because of our small sample size, these data should be interpreted with caution. Wong et al did report a 2-year local recurrence rate of 12.5%. 6 The overall survival rate at 3 years in our study was 78.2%. This rate was higher than the previously reported rates of 28 to 69% in other European studies. 11, 15 The difference is most likely attributable to the fact that our study had a shorter follow-up period.
The main finding in our study is that although some patients experienced recurrence, it was seen in both the RT and non-RT groups. Another significant finding was that 26 of 37 patients who would have been treated with RT according to the DAHANCA guidelines did not receive it and did not experience a recurrence. Although those without RT had less advanced disease, they still avoided RT and its complications. This is consistent with the findings of other studies and should be taken into careful consideration when advising patients as to whether RT or a watch-and-wait approach should be offered. 6, 9 In conclusion, our findings support the trend toward a watch-and-wait approach instead of postoperative RT for patients with close surgical margins and perhaps even for patients with involved margins. Although our retrospective study has some limitations, its results support the need for large, high-quality, prospective, randomized, controlled trials if adherence to current guidelines regarding postoperative RT for inadequate close surgical margins should prove to have only a minor benefit in terms of tumor recurrence and overall survival. However, until such trials are conducted, we find it morally acceptable to pursue a watch-and-wait policy regarding postoperative RT, depending on the TNM status and histopathologic results in patients with inadequate surgical margins.
The decision should be carefully discussed among the surgeon, the oncologic radiotherapist, and the patient. Although the reference laboratory we used is in the upper Midwest region of the United States, the large number of allergens and the significant overlap among regions might make seasonal data applicable to most regions throughout the United States and the perennial allergens applicable more broadly.
In conclusion, wide variability in positive in vitro allergy tests exists, and the likelihood of a positive result in screening panels can be estimated. The most common positive antigens in our study were dog dander (24%), cat dander (23%), dust mites (23% each for D farinae and D pteronyssinus), and June grass (21%). The most common positive food allergen tests were for milk (18%), peanut (17%), wheat (16%), and egg white (15%). The positivity rates for shellfish ranged from 4 to 9%, and the rates for fish were low (3 to 5%). Evaluating these rates will help further identify the most and least common allergens, and there is potential to use the results to identify opportunities to cost-effectively refine allergy screening panels.
